These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24461345)

  • 21. Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up.
    Lenart-Lipińska M; Matyjaszek-Matuszek B; Gernand W; Nowakowski A; Solski J
    Diabetes Res Clin Pract; 2013 Aug; 101(2):194-200. PubMed ID: 23768789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
    Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
    J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
    Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
    Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma norepinephrine is an independent predictor of adverse cerebral and cardiovascular events in type 2 diabetic patients without structural heart disease.
    Yufu K; Okada N; Ebata Y; Murozono Y; Shinohara T; Nakagawa M; Takahashi N
    J Cardiol; 2014 Sep; 64(3):225-30. PubMed ID: 24529506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated microalbuminuria indicates a poor medical prognosis.
    Scheven L; Van der Velde M; Lambers Heerspink HJ; De Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2013 Jul; 28(7):1794-801. PubMed ID: 23493327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
    Ajeganova S; Andersson ML; Frostegård J; Hafström I
    J Rheumatol; 2013 Dec; 40(12):1958-66. PubMed ID: 23950188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does a Mediterranean diet reduce the mortality risk associated with diabetes: evidence from the Melbourne Collaborative Cohort Study.
    Hodge AM; English DR; Itsiopoulos C; O'Dea K; Giles GG
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):733-9. PubMed ID: 21194913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors.
    Gazzaruso C; Solerte SB; Pujia A; Coppola A; Vezzoli M; Salvucci F; Valenti C; Giustina A; Garzaniti A
    J Am Coll Cardiol; 2008 May; 51(21):2040-4. PubMed ID: 18498958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity is associated with lower mortality risk in elderly diabetic subjects: the Casale Monferrato study.
    Perotto M; Panero F; Gruden G; Fornengo P; Lorenzati B; Barutta F; Ghezzo G; Amione C; Cavallo-Perin P; Bruno G
    Acta Diabetol; 2013 Aug; 50(4):563-8. PubMed ID: 22068621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study.
    von Eynatten M; Breitling LP; Roos M; Baumann M; Rothenbacher D; Brenner H
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2327-35. PubMed ID: 22679309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.
    Engelen SE; van der Graaf Y; Stam-Slob MC; Grobbee DE; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Int J Cardiol; 2017 Dec; 248():301-307. PubMed ID: 28802735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes: A cross-sectional survey in China.
    Ren Y; Ren Q; Lu J; Guo X; Huo X; Ji L; Yang X
    Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29124871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Who Must We Target Now to Minimize Future Cardiovascular Events and Total Mortality?: Lessons From the Surveillance, Prevention and Management of Diabetes Mellitus (SUPREME-DM) Cohort Study.
    Desai JR; Vazquez-Benitez G; Xu Z; Schroeder EB; Karter AJ; Steiner JF; Nichols GA; Reynolds K; Xu S; Newton K; Pathak RD; Waitzfelder B; Lafata JE; Butler MG; Kirchner HL; Thomas A; O'Connor PJ;
    Circ Cardiovasc Qual Outcomes; 2015 Sep; 8(5):508-16. PubMed ID: 26307132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nontraditional risk factors for cardiovascular disease in diabetes.
    Fonseca V; Desouza C; Asnani S; Jialal I
    Endocr Rev; 2004 Feb; 25(1):153-75. PubMed ID: 14769830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR).
    Zethelius B; Eliasson B; Eeg-Olofsson K; Svensson AM; Gudbjörnsdottir S; Cederholm J;
    Diabetes Res Clin Pract; 2011 Aug; 93(2):276-284. PubMed ID: 21719139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality and cardiovascular disease outcomes among 740 patients with new-onset Type 2 diabetes detected by screening or clinically diagnosed in general practice.
    Jansson SP; Andersson DK; Svärdsudd K
    Diabet Med; 2016 Mar; 33(3):324-31. PubMed ID: 26516107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased peripheral perfusion measured by perfusion index is a novel indicator for cardiovascular death in patients with type 2 diabetes and established cardiovascular disease.
    Okada H; Tanaka M; Yasuda T; Okada Y; Norikae H; Fujita T; Nishi T; Oyamada H; Yamane T; Fukui M
    Sci Rep; 2021 Jan; 11(1):2135. PubMed ID: 33483575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register.
    Read SH; van Diepen M; Colhoun HM; Halbesma N; Lindsay RS; McKnight JA; McAllister DA; Pearson ER; Petrie JR; Philip S; Sattar N; Woodward M; Wild SH;
    Diabetes Care; 2018 Sep; 41(9):2010-2018. PubMed ID: 30002197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sleep Duration and Risks of Incident Cardiovascular Disease and Mortality Among People With Type 2 Diabetes.
    Han H; Wang Y; Li T; Feng C; Kaliszewski C; Su Y; Wu Y; Zhou J; Wang L; Zong G
    Diabetes Care; 2023 Jan; 46(1):101-110. PubMed ID: 36383480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.